Madison, Wisconsin — According to state and local development sources, Elephas Biosciences plans to build out 8,350 square feet of new space in Madison. The company plans to occupy the new space at 1 Erdman Pl # 100 in Madison, on or about June 1, 2024. According to the company website Cancer is a leading cause of death worldwide, with the number of patients projected to triple by 2060. Despite recent advances in precision medicine and a significant increase in the number of available therapies, only 1 in 3 patients receiving therapy respond. Elephas is solving this problem by developing an imaging platform technology to assess how live tumor fragments respond to cancer therapies. We are removing the trial-and-error approach to cancer care by harnessing the latest advances in cancer biology, multimodal microscopy, and artificial intelligence to accelerate drug development and empower clinical decision making. Our unique approach maintains the native 3-dimensional cellular architecture and micro-environment of the patients tumor, enabling rapid real-time profiling of live tumor samples with immuno-oncology agents, targeted therapies, chemotherapy, and cell therapies.

To learn more about Elephas Biosciences, visit http://elephas.com/

Company Contact:
Maneesh Arora, President and Chief Executive Officer
https://www.linkedin.com/in/maneesh-arora-9b07381/
608-622-7954

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.